These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34118395)

  • 1. Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation.
    Schwarz CG; Therneau TM; Weigand SD; Gunter JL; Lowe VJ; Przybelski SA; Senjem ML; Botha H; Vemuri P; Kantarci K; Boeve BF; Whitwell JL; Josephs KA; Petersen RC; Knopman DS; Jack CR
    Neuroimage; 2021 Sep; 238():118259. PubMed ID: 34118395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.
    Knopman DS; Lundt ES; Therneau TM; Albertson SM; Gunter JL; Senjem ML; Schwarz CG; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Vemuri P; Kantarci K; Lowe VJ; Petersen RC; Jack CR;
    JAMA Neurol; 2021 Feb; 78(2):217-228. PubMed ID: 33074304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial volume correction in longitudinal tau PET studies: is it really needed?
    Costoya-Sánchez A; Moscoso A; Sobrino T; Ruibal Á; Grothe MJ; Schöll M; Silva-Rodríguez J; Aguiar P;
    Neuroimage; 2024 Apr; 289():120537. PubMed ID: 38367651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [
    Young CB; Landau SM; Harrison TM; Poston KL; Mormino EC;
    Neuroimage; 2021 Nov; 243():118553. PubMed ID: 34487825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced [
    Moscoso A; Grothe MJ; Schöll M;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2283-2294. PubMed ID: 33475761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia.
    Pontecorvo MJ; Devous MD; Kennedy I; Navitsky M; Lu M; Galante N; Salloway S; Doraiswamy PM; Southekal S; Arora AK; McGeehan A; Lim NC; Xiong H; Truocchio SP; Joshi AD; Shcherbinin S; Teske B; Fleisher AS; Mintun MA
    Brain; 2019 Jun; 142(6):1723-1735. PubMed ID: 31009046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal tau PET in ageing and Alzheimer's disease.
    Jack CR; Wiste HJ; Schwarz CG; Lowe VJ; Senjem ML; Vemuri P; Weigand SD; Therneau TM; Knopman DS; Gunter JL; Jones DT; Graff-Radford J; Kantarci K; Roberts RO; Mielke MM; Machulda MM; Petersen RC
    Brain; 2018 May; 141(5):1517-1528. PubMed ID: 29538647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease.
    Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y
    Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR.
    Schwarz CG; Gunter JL; Lowe VJ; Weigand S; Vemuri P; Senjem ML; Petersen RC; Knopman DS; Jack CR
    J Alzheimers Dis; 2019; 67(1):181-195. PubMed ID: 30475770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracer-specific reference tissues selection improves detection of
    Li Y; Ng YL; Paranjpe MD; Ge Q; Gu F; Li P; Yan S; Lu J; Wang X; Zhou Y;
    Hum Brain Mapp; 2022 May; 43(7):2121-2133. PubMed ID: 35165964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
    Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
    J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test-retest repeatability of [
    Timmers T; Ossenkoppele R; Visser D; Tuncel H; Wolters EE; Verfaillie SC; van der Flier WM; Boellaard R; Golla SS; van Berckel BN
    J Cereb Blood Flow Metab; 2020 Dec; 40(12):2464-2474. PubMed ID: 31575335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks.
    Schumacher J; Gunter JL; Przybelski SA; Jones DT; Graff-Radford J; Savica R; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Knopman DS; Fields JA; Kremers WK; Petersen RC; Graff-Radford NR; Ferman TJ; Boeve BF; Thomas AJ; Taylor JP; Kantarci K
    Brain; 2021 Nov; 144(10):3212-3225. PubMed ID: 34114602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
    Leuzy A; Binette AP; Vogel JW; Klein G; Borroni E; Tonietto M; Strandberg O; Mattsson-Carlgren N; Palmqvist S; Pontecorvo MJ; Iaccarino L; Stomrud E; Ossenkoppele R; Smith R; Hansson O;
    JAMA Neurol; 2023 Jun; 80(6):614-623. PubMed ID: 37155176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
    Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
    JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct Comparison of the Tau PET Tracers
    Gogola A; Minhas DS; Villemagne VL; Cohen AD; Mountz JM; Pascoal TA; Laymon CM; Mason NS; Ikonomovic MD; Mathis CA; Snitz BE; Lopez OL; Klunk WE; Lopresti BJ
    J Nucl Med; 2022 Jan; 63(1):108-116. PubMed ID: 33863821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity.
    Southekal S; Devous MD; Kennedy I; Navitsky M; Lu M; Joshi AD; Pontecorvo MJ; Mintun MA
    J Nucl Med; 2018 Jun; 59(6):944-951. PubMed ID: 29191858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parametric Estimation of Reference Signal Intensity for Semi-Quantification of Tau Deposition: A Flortaucipir and [
    Zhang H; Wang M; Lu J; Bao W; Li L; Jiang J; Zuo C;
    Front Neurosci; 2021; 15():598234. PubMed ID: 34234637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.